FIGURE 4.
Duration of response [partial response with lymphocytosis (PR‐L) or better] in Chinese patients with relapsed/refractory (R/R) B‐cell malignancies receiving zanubrutinib. Response was defined as PR‐L or better
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.